...
首页> 外文期刊>Pesquisa Veterinaria Brasileira >Development and standardization of Dot-ELISA using recombinant peptides for serological diagnosis of Neospora caninum
【24h】

Development and standardization of Dot-ELISA using recombinant peptides for serological diagnosis of Neospora caninum

机译:用于重组犬新孢子虫血清学诊断的Dot-ELISA的开发和标准化

获取原文
获取原文并翻译 | 示例

摘要

Neosporosis is recognized as a major cause of abortion and neonatal loss in cattle worldwide, both for dairy cattle and beef cattle. In recent years this disease has attracted the interest of researchers and studying the epidemiology and effective methods of diagnosis of this disease. The present study aimed to develop and standardize on a Dot-ELISA for the serological diagnosis of Neospora caninum by using recombinant peptide as antigen for the development of a diagnostic kit used on the field. The recombinant antigen (rNcGRA1) was designed based on the method of reverse genetics derived antigenic epitopes of dense granules protein of N. can mum and synthesized by GenScript (USA). It was produced by the fermentation in yeasts Pichiapastoris KM71. The serological technique was used for the Dot-ELISA detection of IgG specific for N. caninum in which 0.22 mu m nitrocellulose membranes were sensitized with 1 mu L of antigen and subsequently the plasmas were diluted in a washing solution and incubated for 1 hour The results will revealed by the addition of Protein G labeled with peroxidasse for 30 minutes, followed by the developing solution based on 3,3'-Diaminobenzidine (DAB). Soon after standardization tested 44 bovine plasmas were diagnosed by indirect immunofluorescence assay (IFA), agreeing with the results on a 95.5% and a sensitivity and specificity of 100% and 92% respectively. In regard to the diagnostic kit for the Technology Platform Rapid Flow-Through Miriad(R), the peptide presented rNcGRA1 visible markings to react with positive plasma, and showed no markings using the negative plasma. This study is the first to use recombinant peptides and prove to be efficient for the serological diagnosis of cattle naturally infected.
机译:新孢子虫病被认为是全世界奶牛和肉牛流产和新生儿流失的主要原因。近年来,这种疾病引起了研究人员的兴趣,并研究了该疾病的流行病学和有效的诊断方法。本研究旨在通过使用重组肽作为抗原开发用于现场诊断试剂盒的犬新孢子虫血清学诊断的Dot-ELISA,并使之标准化。重组抗原(rNcGRA1)是根据反向遗传学的方法设计的,由GenScript(美国)合成了猪笼草的致密颗粒蛋白的抗原表位并合成。它是通过在酵母毕赤酵母KM71中发酵产生的。使用血清学技术对犬新孢子虫特异性IgG进行Dot-ELISA检测,其中将0.22μm硝化纤维素膜用1μL抗原敏化,然后将血浆在洗涤液中稀释并孵育1小时。将通过添加用过氧化物酶标记的蛋白质G持续30分钟,然后添加基于3,3'-二氨基联苯胺(DAB)的显影液来显示。标准化测试后不久,通过间接免疫荧光分析(IFA)诊断出44个牛血浆,其结果分别为95.5%,敏感性和特异性分别为100%和92%。关于用于技术平台快速流通的诊断试剂盒,该肽呈现出rNcGRA1可见标记以与阳性血浆反应,而使用阴性血浆则没有标记。这项研究是首次使用重组肽,并被证明对于自然感染牛的血清学诊断是有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号